Funding The authors declare no grants or financial support for the research, authorship, and publication of this article
Furthermore, dedicated cardiovascular outcome trials (LEADER, SUSTAIN-6, REWIND)[26, 28, 29] have demonstrated consistent reduction in major adverse cardiovascular events with long-acting GLP-1 RAs, particularly in people with established ASCVD
For example, a patient might use phentermine to kickstart their weight loss, then switch to a GLP-1 medication for long-term maintenance
Medicines That May Need Closer Monitoring Because Mounjaro slows digestion, it may affect the absorption of some oral medicines
Los estudios clnicos con medicamentos basados en GLP-1 han demostrado reducciones significativas de peso corporal